Skip to main content

February 2024

 

 

academics

 

Clinical research courses

Online applications are invited for Pharma Faculty at Central University of Haryana

Central University of Haryana is one of the fifteen new Central Universities established by Ministry of Human Resource Development, Government of India (GoI) in XI Five Year Plan (2007-2012) under the Central University Act-2009 of the Parliament.  The University has been accredited with A Grade in the first cycle of NAAC assessment and accreditation conducted in March 2017.

Institute of Nano Science and Technology Ph.D Program - August 2024

Institute of Nano Science and Technology, Mohali, Punjab, an autonomous institution of Department of Science and Technology, Government of India, has been established under the umbrella of NANO MISSION, initiated by DST to boost research and development in the field of Nanoscience and Nanotechnology in India. INST started its activities on 3rd January 2013, the date on which its first Director was appointed.

Ph.D. PROGRAM - AUGUST 2024 SESSION

Vacancy for Junior Research Fellow at National Institute of Immunology

The National Institute of Immunology (NII) is committed to advanced research addressing the basic mechanisms involved in body's defence to identify modalities for manipulation of the immune system to provide protection against diseases and understand mechanisms that can be used to target disease processes for intervention.

Post : Junior Research Fellow (Project)

Intas Pharma Walk in Drive for D.Pharm, B.Pharm, M.Pharm in Solid Oral Packing

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.

Post : Technician / Officer / Sr. Officer

Inviting Formulation R&D (Injectables) Experienced Professionals at Gland Pharma

Gland Pharma is the worlds leading player in Injectables Formulation and Manufacturing. It is also into API and Intermediates research and manufacturing. Gland Pharma is present in sterile injectables, oncology and ophthalmic segments, and focus on complex injectables including NCE-1s, First-to-File products and 505b2 filings.

Inviting Formulation R&D (Injectables) Experienced Professionals.

Walk in Drive for B.Pharm, MSc in Production, QC at Ind Swift Limited

Ind-Swift Limited - Jawaharpur, Derabassi is the Ace unit of Ind-Swift Limited, was created in the year 2006 with an aim to globalize the Ind-Swift brand for finished dosage forms. We are a 100% Export Oriented Formulation Unit dealing in regulated markets having approval like MHRA-UK, MOH-CANADA, TGA & ROW etc.

Interview for D.Pharm, B.Pharm, BSc in Production, Stores at Medreich

Medreich is a fully integrated pharmaceutical company with an established presence across the globe. The company is involved in the CMO & CDMO business of pharmaceutical preparations in various dosage forms catering to diverse Therapeutic categories.  Medreich has an advanced state of the art Research and Development centre with proven scientific competence to develop formulations as Patent Non-infringing and Niche generics in differentiated dosage form for global regulated markets.

Roche Pharma launches ocrelizumab in India after six years of global release

Roche Pharma launches ocrelizumab in India, six years after global release. Ocrelizumab is an FDA-approved CD20-directed humanized monoclonal antibody indicated to treat adult patients with primary progressive or relapsing multiple sclerosis.

PHARMA ANVESHAN 2024 Organised by Pharmacy Council of India and Bhagwan Mahavir College of Pharmacy

The Pharmacy Council of India (PCI) is a statutory body working under the Ministry of Health and Family Welfare, Government of India. It is constituted under the Pharmacy Act, 1948 to regulate pharmacy education & practice of profession in the country.

100 Rs tablet prevents spread of cancer, breakthrough research by Indian Scientists

The breakthrough research by TATA memorial centre scientists who have developed a tablet which reduces side effects of cancer treatment and prevent resurgence or relapse of cancer said Dr Rajendra Badwe, Director of the Tata Memorial Centre in an interview with NDTV. The said tablet will be available at an affordable price of Rs. 100 a tablet.